These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 73419)

  • 1. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
    Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
    McMahon LJ; Jones SE; Durie BG; Salmon SE
    Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma.
    Samuels ML; Barkley HT; Holoye PY; Rosenberg PJ; Smith TL
    Cancer Chemother Rep; 1975; 59(2 Pt 1):377-83. PubMed ID: 50124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
    Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for lung cancer.
    Golbey RB
    Postgrad Med; 1978 Feb; 63(2):137-41. PubMed ID: 75540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck.
    Livingston RB; Einhorn LH; Burgess MA; Gottlieb JA
    Cancer Treat Rep; 1976 Jan; 60(1):103-5. PubMed ID: 63330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
    Gropp C; Havemann K; Gassel WD; Hess F; Prignitz R; Schmidt M; Sodomann CP
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec; 90(3):301-6. PubMed ID: 146331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oat cell carcinoma of the lung: combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate.
    Wittes RE; Hopfan S; Hilaris B; Golbey RB; Melamed M; Martini N
    Cancer; 1977 Aug; 40(2):653-9. PubMed ID: 196737
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY; Samuels ML; Smith T; Sinkovics JG
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polychemotherapy of inoperable bronchogenic carcinoma: preliminary results (author's transl)].
    Schulz V; Busch S; Endres P; Rubin R; Schönen M
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():660-1. PubMed ID: 88732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in bronchogenic carcinoma.
    Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
    Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.